# Prospective Survey of Menstrual Migraine & Prevention With Eletriptan

> **NCT00259649** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 71 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** eletriptan

## Key facts

- **NCT ID:** NCT00259649
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2008-08
- **Final completion:** —
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2011-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259649, "Prospective Survey of Menstrual Migraine & Prevention With Eletriptan". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00259649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*